Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1986 2
1987 1
1990 1
1991 1
1992 1
1993 3
1994 4
1995 1
1997 2
1998 2
1999 1
2000 2
2001 2
2002 4
2003 8
2004 9
2005 7
2006 6
2007 7
2008 2
2009 9
2010 7
2011 6
2012 6
2013 7
2014 8
2015 3
2016 4
2017 6
2018 4
2019 7
2020 10
2021 2
2022 4
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Results by year

Filters applied: . Clear all
Page 1
Challenges in glioblastoma research: focus on the tumor microenvironment.
Bikfalvi A, da Costa CA, Avril T, Barnier JV, Bauchet L, Brisson L, Cartron PF, Castel H, Chevet E, Chneiweiss H, Clavreul A, Constantin B, Coronas V, Daubon T, Dontenwill M, Ducray F, Enz-Werle N, Figarella-Branger D, Fournier I, Frenel JS, Gabut M, Galli T, Gavard J, Huberfeld G, Hugnot JP, Idbaih A, Junier MP, Mathivet T, Menei P, Meyronet D, Mirjolet C, Morin F, Mosser J, Moyal EC, Rousseau V, Salzet M, Sanson M, Seano G, Tabouret E, Tchoghandjian A, Turchi L, Vallette FM, Vats S, Verreault M, Virolle T. Bikfalvi A, et al. Among authors: vallette fm. Trends Cancer. 2023 Jan;9(1):9-27. doi: 10.1016/j.trecan.2022.09.005. Epub 2022 Nov 16. Trends Cancer. 2023. PMID: 36400694 Review.
Cell-free circulating epimarks in cancer monitoring.
Duforestel M, Briand J, Bougras-Cartron G, Heymann D, Frenel JS, Vallette FM, Cartron PF. Duforestel M, et al. Among authors: vallette fm. Epigenomics. 2020 Jan;12(2):145-155. doi: 10.2217/epi-2019-0170. Epub 2020 Jan 9. Epigenomics. 2020. PMID: 31916450 Review.
Three-dimensional in vitro culture models in oncology research.
Jubelin C, Muñoz-Garcia J, Griscom L, Cochonneau D, Ollivier E, Heymann MF, Vallette FM, Oliver L, Heymann D. Jubelin C, et al. Among authors: vallette fm. Cell Biosci. 2022 Sep 11;12(1):155. doi: 10.1186/s13578-022-00887-3. Cell Biosci. 2022. PMID: 36089610 Free PMC article. Review.
Challenges in glioblastoma research: focus on the tumor microenvironment: (Trends in Cancer, 9:1 p:9-27, 2023).
Bikfalvi A, da Costa CA, Avril T, Barnier JV, Bauchet L, Brisson L, Cartron PF, Castel H, Chevet E, Chneiweiss H, Clavreul A, Constantin B, Coronas V, Daubon T, Dontenwill M, Ducray F, Entz-Werlé N, Figarella-Branger D, Fournier I, Frenel JS, Gabut M, Galli T, Gavard J, Huberfeld G, Hugnot JP, Idbaih A, Junier MP, Mathivet T, Menei P, Meyronet D, Mirjolet C, Morin F, Mosser J, Moyal EC, Rousseau V, Salzet M, Sanson M, Seano G, Tabouret E, Tchoghandjian A, Turchi L, Vallette FM, Vats S, Verreault M, Virolle T. Bikfalvi A, et al. Among authors: vallette fm. Trends Cancer. 2023 Aug;9(8):692. doi: 10.1016/j.trecan.2023.02.006. Epub 2023 Mar 28. Trends Cancer. 2023. PMID: 36997420 No abstract available.
Drug resistance in glioblastoma: are persisters the key to therapy?
Oliver L, Lalier L, Salaud C, Heymann D, Cartron PF, Vallette FM. Oliver L, et al. Among authors: vallette fm. Cancer Drug Resist. 2020 Aug 7;3(3):287-301. doi: 10.20517/cdr.2020.29. eCollection 2020. Cancer Drug Resist. 2020. PMID: 35582442 Free PMC article. Review.
Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress.
Olivier C, Oliver L, Lalier L, Vallette FM. Olivier C, et al. Among authors: vallette fm. Front Mol Biosci. 2021 Jan 27;7:620677. doi: 10.3389/fmolb.2020.620677. eCollection 2020. Front Mol Biosci. 2021. PMID: 33585565 Free PMC article. Review.
142 results